Posted in

Executive Director – Worldwide Medical Affairs Disease Area Head GI/GU Cancers

Executive Director – Worldwide Medical Affairs Disease Area Head GI/GU Cancers

CompanyBristol Myers Squibb
LocationSummit, NJ, USA, Uxbridge, UK, Princeton, NJ, USA
Salary$Not Provided – $Not Provided
TypeFull-Time
DegreesMD
Experience LevelSenior, Expert or higher

Requirements

  • Medical Degree (MD or equivalent) with clinical experience in oncology preferred.
  • 7+ years of leadership experience in the biopharmaceutical industry or academia with a strong track record in oncology and global medical affairs.
  • Demonstrated expertise in building and executing global medical and portfolio strategies for marketed and pipeline assets in the relevant disease areas.
  • Proven ability to lead and inspire large, diverse, and geographically distributed teams.
  • Strong knowledge of global regulatory landscapes, clinical development, access and medical launch excellence.
  • Exceptional stakeholder management and communication skills, with the ability to influence and build credibility with senior leadership, external partners, and the global scientific community.
  • Strategic thinking and business acumen.
  • Excellent communication and interpersonal skills.
  • Strong analytical and problem-solving abilities.
  • Ability to work collaboratively across functions and geographies.
  • Commitment to patient-centric care and scientific excellence.

Responsibilities

  • Develop and execute the global medical strategy for GI, GU cancers, aligning with organizational goals and patient needs.
  • Anticipate and respond to dynamic market landscapes, including scientific, regulatory, and competitive challenges, ensuring a leadership position in the global oncology market.
  • Collaborate with R&D, Commercial, and Market Access teams to shape pipeline and portfolio strategies that deliver life-changing therapies to patients.
  • Identify unmet needs, market trends, and opportunities for new product development or acquisitions in GI, GU cancers.
  • Oversee differentiation strategies and signal-seeking initiatives to expand the pipeline and identify transformative therapeutic opportunities.
  • Shape early development strategy and contribute to trial designs and recruitment.
  • Ensure appropriate access for patients across US and international markets.
  • Oversee the Medical Product Leads (MPL) and AIMs (Asset Integrated Medical Teams) to ensure strategy is co-created with the markets and that asset strategies reflect the needs of our countries while driving top market performance and support.
  • Serve as the key medical representative on the brand team and Global Product Teams, providing strategic leadership and scientific expertise.
  • Collaborate with cross-functional teams to ensure evidence generation efforts support regulatory submissions, reimbursement decisions, and market access strategy.
  • Responsible for the Disease area Evidence generation strategies; accountable for the integrated evidence plans and prioritize studies to address key stakeholders’ needs, including patients, healthcare providers, and payors.
  • Oversee the design and implementation of interventional trials and real-world evidence (RWE) studies, including early signal-seeking studies, investigator-sponsored research (ISR), medical affairs-led studies, post-market studies, registries, and observational research.
  • Lead a high-performing, inclusive, and diverse team of medical and scientific professionals, fostering a culture of accountability, collaboration, and empowerment to achieve exceptional results.
  • Champion organizational efficiency and agility by implementing streamlined processes that enable seamless global execution of strategic programs, initiatives, and high-impact launches.
  • Leverage advanced digital capabilities and data-driven tools to optimize decision-making, enhance stakeholder engagement, and provide actionable insights that shape medical and business strategies.
  • Establish and maintain robust systems to ensure a relentless focus on measurable outcomes across all medical activities, tracking and evaluating performance metrics to drive sustained impact, operational excellence, and continuous improvement.
  • Serve as the global medical face of the organization GI, GU, representing the company with key external stakeholders, including regulatory agencies, academic and community institutions, medical organizations, population decision-makers, and patient advocacy groups.
  • Lead efforts to strengthen the company’s reputation as the partner of choice in the oncology space by advancing our commitment to patient-centric care and science-driven solutions.
  • Establish strategic partnerships to accelerate access, innovation, and scientific collaboration globally.

Preferred Qualifications

  • Medical Degree (MD or equivalent) with clinical experience in oncology preferred.